Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach
Proceedings of the National Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
121(42)
Published: Oct. 10, 2024
Chikungunya
virus
(CHIKV)
is
a
mosquito-borne
alphavirus
that
has
been
responsible
for
numerous
large-scale
outbreaks
in
the
last
twenty
years.
Currently,
there
are
no
FDA-approved
therapeutics
any
infection.
CHIKV
nonstructural
protein
2
(nsP2),
which
contains
cysteine
protease
domain,
essential
viral
replication,
making
it
an
attractive
target
drug
discovery
campaign.
Here,
we
optimized
nsP2
(nsP2pro)
biochemical
assay
screening
of
6,120-compound
cysteine-directed
covalent
fragment
library.
Using
50%
inhibition
threshold,
identified
153
hits
(2.5%
hit
rate).
In
dose–response
follow-up,
RA-0002034,
vinyl
sulfone
warhead,
inhibited
nsP2pro
with
IC
50
58
±
17
nM,
and
further
analysis
time-dependent
studies
yielded
k
inact
/K
I
6.4
×
10
3
M
−1
s
.
LC-MS/MS
determined
RA-0002034
covalently
modified
catalytic
site-specific
manner.
Additionally,
showed
significant
off-target
reactivity
proteomic
experiments
or
against
panel
proteases.
addition
to
potent
activity
exceptional
selectivity,
was
tested
cellular
models
infection
effectively
replication
both
related
alphaviruses.
This
study
highlights
identification
characterization
chemical
probe
as
promising
compound
from
fragment-based
development
toward
pan-alphavirus
therapeutic.
Language: Английский
Structure Activity of β-Amidomethyl Vinyl Sulfones as Covalent Inhibitors of Chikungunya nsP2 Cysteine Protease with Antialphavirus Activity
Journal of Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
67(18), P. 16505 - 16532
Published: Sept. 5, 2024
Despite
their
widespread
impact
on
human
health,
there
are
no
approved
drugs
for
combating
alphavirus
infections.
The
heterocyclic
β-aminomethyl
vinyl
sulfone
RA-0002034
(
Language: Английский
Species Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with in Vivo Anti-alphaviral Activity
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 16, 2025
Abstract
RA-0002034
(
1
)
is
a
potent
covalent
inhibitor
targeting
the
alphavirus
nsP2
cysteine
protease.
The
species-dependent
pharmacokinetics
and
metabolism
of
were
investigated
to
evaluate
its
therapeutic
potential.
Pharmacokinetic
profiling
revealed
rapid
clearance
in
mice,
predominantly
mediated
by
glutathione
S
-transferase
(GST)-catalyzed
conjugation.
This
metabolic
liability
contrasted
with
slower
observed
human
hepatocytes
preclinical
species
such
as
rats,
dogs,
monkeys.
Cross-species
studies
confirmed
dominance
GST-driven
whereas
oxidative
pathways
more
pronounced
dogs.
Despite
systemic
clearance,
achieved
antiviral
efficacy
reducing
CHIKV
viral
loads
multiple
tissues.
Initial
estimations
hepatic
half-life
extrapolated
from
animal
data
indicate
that
b.i.d.
dosing
will
be
possible
maintain
concentrations
sufficient
for
activity
humans.
These
cross-species
pharmacokinetic
support
continued
evaluation
promising
anti-alphaviral
therapeutic.
Graphical
Language: Английский
A covalent chemical probe for Chikungunya nsP2 cysteine protease with antialphaviral activity and proteome-wide selectivity
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: March 1, 2025
Language: Английский
Species-Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with In Vivo Antialphaviral Activity
Journal of Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 12, 2025
RA-0002034
(1)
is
a
potent
covalent
inhibitor
targeting
the
nsP2
cysteine
protease.
The
species-dependent
pharmacokinetics
and
metabolism
of
1
were
investigated
to
evaluate
its
therapeutic
potential.
Pharmacokinetic
profiling
revealed
rapid
clearance
in
mice,
predominantly
mediated
by
glutathione
S-transferase
(GST)-catalyzed
conjugation.
This
metabolic
liability
contrasted
with
slower
observed
human
hepatocytes
preclinical
species,
such
as
rats,
dogs,
monkeys.
Cross-species
studies
confirmed
dominance
GST-driven
whereas
oxidative
pathways
more
pronounced
dogs.
Despite
systemic
clearance,
achieved
antiviral
efficacy
reducing
chikungunya
(CHIKV)
viral
loads
multiple
tissues.
These
cross-species
pharmacokinetic
support
continued
evaluation
potential
antialphaviral
further
define
contribution
hepatic
non-hepatic
GST
humans.
Language: Английский
Structure Activity of β-Amidomethyl Vinyl Sulfones as Covalent Inhibitors ofChikungunyansP2 Cysteine Protease with Anti-alphavirus Activity
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 13, 2024
Despite
their
widespread
impact
on
human
health
there
are
no
approved
drugs
for
combating
alphavirus
infections.
The
heterocyclic
β-aminomethyl
vinyl
sulfone
RA-0002034
(
Language: Английский